COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III

NCT04327401 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

299

Enrollment

OTHER

Sponsor class

Stopped The Data Monitoring Committee recommended to stop the trial based on the Recovery Trial results, which was accepted by the CoDEX Steering Committee.

Conditions

Coronavirus Infection
Pneumonia, Viral
Acute Respiratory Distress Syndrome

Interventions

DRUG: Dexamethasone

Sponsor

Hospital Sirio-Libanes

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]